Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus

By McLain L.   Durrani Z.   Wisniewski L.A.   Porta C.   Lomonossoff G.P.   Dimmock N.J.  

Vaccine, Vol. 14, Iss. 8, 1996-06 ,pp. : 799-810

Elsevier

Access to resources Recommend Favorite

Broadly reactive antibodies against a gp120 V3 loop multi-epitope polypeptide neutralize different isolates of human immunodeficiency virus type 1 (HIV-1)

By Montero M.   Menendez A.   del Carmen Dominguez M.   Navea L.   Vilarubia O.L.   Quintana D.   Izquierdo M.   Jimenez V.   Reyes O.   Lobaina L.   Noa E.   Duarte C.A.  

Vaccine, Vol. 15, Iss. 11, 1997-08 ,pp. : 1200-1208

Elsevier

Access to resources Recommend Favorite

Neutralizing antibodies against highly cytopathic Zairian human immunodeficiency type-1 virus (HIV-1) NDK are present in sera outside Africa

By Machado A.A.   Baknabua M.   Salaun D.   de Mareuil J.   Krciinak V.   MacGregor R.R.   Chermann J.-C.   Hirsch I.  

Vaccine, Vol. 13, Iss. 3, 1995-01 ,pp. : 321-325

Elsevier

Access to resources Recommend Favorite

Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies, cytotoxic T lymphocytes and mucosal IgA

By Marinaro M.   Riccomi A.   Rappuoli R.   Pizza M.   Fiorelli V.   Tripiciano A.   Cafaro A.   Ensoli B.   De Magistris M.T.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3972-3981

Elsevier

Access to resources Recommend Favorite

Binding of antibodies to human immunodeficiency virus type 1 (HIV-1)-infected lymphocytes elicited by vaccines and by natural infection

By Gorse G.J.   Patel G.B.   Arbuckle J.A.   Belshe R.B.  

Vaccine, Vol. 22, Iss. 3, 2004-01 ,pp. : 383-397

Elsevier

Access to resources Recommend Favorite